Protection against influenza virus infection by nasal vaccination in advance of sublethal irradiation

By Hasegawa H.   Kadowaki S.-e.   Takahashi H.   Iwasaki T.   Tamura S.-i.   Kurata T.  

Vaccine, Vol. 18, Iss. 23, 2000-05 ,pp. : 2560-2565

Elsevier

Access to resources Recommend Favorite

IgA antibody-forming cell responses in the nasal-associated lymphoid tissue of mice vaccinated by intranasal, intravenous and/or subcutaneous administration

By Asanuma H.   Aizawa C.   Kurata T.   Tamura S.-i.  

Vaccine, Vol. 16, Iss. 13, 1998-08 ,pp. : 1257-1262

Elsevier

Access to resources Recommend Favorite

Cross-protection against influenza virus infection in mice vaccinated by combined nasal/subcutaneous administration

By Asanuma H.   Koide F.   Suzuki Y.   Nagamine T.   Aizawa C.   Kurata T.   Tamura S.-i.  

Vaccine, Vol. 13, Iss. 1, 1995-01 ,pp. : 3-5

Elsevier

Access to resources Recommend Favorite

Salbutamol as an adjuvant for nasal vaccination

By Fermin Z.   Bout D.   Ricciardi-Castagnoli P.   Hoebeke J.  

Vaccine, Vol. 17, Iss. 15, 1999-04 ,pp. : 1936-1941

Elsevier

Access to resources Recommend Favorite

Persistent infection of influenza virus in irradiated mice and its prevention by intranasal vaccination

By Hasegawa H.   Kadowaki S.-e.   Watanabe I.   Aizawa H.   Takahashi H.   Iwasaki T.   Tamura S.-i.   Kurata T.   Sata T.  

Vaccine, Vol. 20, Iss. 7, 2002-01 ,pp. : 1050-1057

Elsevier

Access to resources Recommend Favorite